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Learning objectives:  
1. Explain the ideas behind the use of microcontainers 
2. Describe which types of compounds that can be filled into microcontainers 
3. Evaluate the in vivo performance of microcontainers as an oral drug delivery system  
 
INTRODUCTION: Microcontainers are polymeric, cylindrical devices in micrometer size and have been 
proven useful in oral drug delivery1-3. The hypothesis is that oral bioavailability can be improved 
significantly by utilizing microcontainers loaded with drug(s) and sealed with lids protecting the drug 
through the gastrointestinal tract. The purpose of this work was to fabricate microcontainers from either 
SU-8 or from biodegradable polymers such as polycaprolactone (PCL), and to load these microcontainers 
with either poorly water soluble drugs or particulates. Furthermore, the aim was to investigate the 
application of microcontainers as oral drug delivery system in terms of release, mucoadhesion and oral 
bioavailability in rats.  
METHODS: SU-8 microcontainers were fabricated using lithography, whereas PCL microcontainers were 
prepared by hot punching. Subsequently, drug was loaded into the microcontainers using a variety of 
technologies. The SU-8 microcontainers were filled with polyvinylpyrrolidone (PVP) followed by 
supercritical CO2 impregnation of e.g ketoprofen into the PVP matrix. As an alternative filling method, the 
powder of amorphous sodium salt of furosemide (ASSF) or lipid particulates with ovalbumin were filled into 
the SU-8 microcontainers. The PCL microcontainers were loaded with drug formulation by embossing the 
microcontainers into a drug/polymer layer. In most cases, an enteric-resistant lid of Eudragit L100 was 
spray coated onto the cavity of the microcontainers. Release of drug from the coated microcontainers was 
investigated using a µ-Diss profiler (Pion, USA) in simulated gastric medium at pH 2 and intestinal medium 
at pH 6.5. Closed loop in situ intestinal perfusion studies as well as in vivo studies in rats were performed to 
study the mucoadhesive effect of microcontainers and oral bioavailability of the drugs loaded into the 
microcontainers.  
RESULTS: SU-8 microcontainers had an inner diameter of 220 µm and a cavity depth of 270 µm (Fig. 1a, 1b), 
whereas the PCL microcontainers had an inner diameter of 240 µm and a cavity depth of 65 µm. A fast 
release of ASSF (88% within 3h) or ketoprofen (100% within 6h) from the microcontainers was observed 
and the Eudragit coating was shown not to be a hindrance for rapid release at intestinal conditions. It was 
shown that the microcontainers only attached to the mucus layer in the intestine and not in the stomach. 
For ASSF, the microcontainers were seen to increase the relative oral bioavailability by 220% within 24h, 
compared to the control (Fig. 2).  
CONCLUSIONS: The fabricated microcontainers show considerable future potential as oral drug delivery 
systems. 
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a) b)
Fig 1. a) Photograph of microcontainers placed on a finger. The
microcontainers have a size comparable to sugar grains. b) Image of an
SU-8 microcontainer.
Fig. 2: Plasma concentrations of microcontainers filled with ASSF coated 
with Eudragit® L100 and filled into capsules and ASSF dosed in capsules 
with Eudragit coating after orally dosing to rats 
